Rhenman & Partners Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Rhenman & Partners Asset Management's AMGN Position: Q1 2026 in Review
Rhenman & Partners Asset Management reduced its Amgen (AMGN) stake by 58% in Q1 2026, selling an estimated $7.42M and leaving 15,200 shares worth $5.35M. The position accounts for 0.66% of the portfolio, ranked #55.
Rhenman & Partners Asset Management first reported a position in AMGN in Q1 2014 and has held it in 22 quarters since. The position peaked at $18.7M in Q3 2015. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Rhenman & Partners Asset Management held 15,200 shares of Amgen worth $5.35M as of Q1 2026.
- Rhenman & Partners Asset Management sold 20,800 Amgen shares in Q1 2026, an estimated $7.42M.
- Amgen made up 0.66% of Rhenman & Partners Asset Management's portfolio in Q1 2026, its #55 holding.
- Rhenman & Partners Asset Management first reported a position in Amgen in Q1 2014 and has held it in 22 quarters since.
- Rhenman & Partners Asset Management's Amgen position peaked at $18.7M in Q3 2015.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.